Pyrazinecarbonitrile (CAS 19847-12-2): Properties, Synthesis, and Pharmaceutical Applications

A vital building block in modern chemistry, crucial for drug development and organic synthesis.

Get a Quote & Sample

Benefits Derived from the Product

Enhanced Pharmaceutical Synthesis

Leveraging Pyrazinecarbonitrile as a core component allows for more efficient and effective synthesis of vital pharmaceutical compounds, directly impacting drug development timelines and product quality. Its role in creating pyrazinamide is a prime example of its therapeutic significance.

Versatile Organic Building Block

As a flexible heterocyclic compound, Pyrazinecarbonitrile facilitates a broad spectrum of organic reactions, enabling chemists to construct novel molecular architectures for various applications, including agrochemicals and advanced materials. This versatility is a cornerstone of its value.

Guaranteed Quality and Purity

Adherence to high pyrazinecarbonitrile quality standards ensures that the material is free from detrimental impurities, which is crucial for applications where precision and safety are paramount, such as in pharmaceutical manufacturing.

Key Applications

Pharmaceutical Manufacturing

Pyrazinecarbonitrile is indispensable in the synthesis of active pharmaceutical ingredients (APIs), with its primary application being the production of pyrazinamide, a vital drug used in the treatment of tuberculosis.

Fine Chemical Synthesis

As a versatile intermediate, it is employed in a wide range of organic synthesis reactions to create complex molecules and specialized chemicals for various industrial sectors.

Research and Development

Its unique chemical properties make it a valuable compound for researchers exploring new synthetic methodologies and developing novel compounds with potential therapeutic or industrial applications.

Agrochemicals Development

Pyrazine derivatives, which can be synthesized using Pyrazinecarbonitrile, are also found to be useful in the development of advanced agrochemical products.